News | December 20, 2010

MR System Offers Better Image Quality for Advanced Applications

December 20, 2010 – A magnetic resonance (MR) system with high slew rate gradients and a new user interface is pending 510(k) approval and was announced at the Radiological Society of North America (RSNA) annual meeting. The Vantage Titan HSR 1.5T MR, by Toshiba, is ideal for exams, such as advanced cardiac and neuro imaging, that require higher image quality and faster exams.

The high slew rate gradients (gradient strength 30 [mT/m] | slew rate 203 [mT/m/ms]) improve the capability for advanced cardiac and neuro applications as well as magnetic resonance angiography (MRA) body, breast and abdominal imaging. They also improve temporal and spatial resolution and the ability for clinicians to make accurate diagnoses. The M-Power interface has new efficiency tools as well as advanced post-processing software, enhancing department workflow.

The system also features an open bore that is 18 percent larger than other 1.5T systems on the market and features a large 71 cm patient aperture and outstanding homogeneity. It also has the largest available clinical field-of-view of 55 x 55 x 50 cm.

The system is an enhancement to the Vantage Titan and therefore includes numerous patient-focused features that significantly improve comfort and increase the range of patients who can be imaged. The open bore provides a greater feeling of openness for the patient, and Pianissimo technology dramatically reduces acoustic noise. It also utilizes Atlas Speeder integrated coil technology to reduce exam time. Since the coils are integrated into the table, patients do not need to be continually repositioned. Additionally, many procedures can be performed feet first, reducing claustrophobia.

The system also takes advantage of Toshiba’s contrast-free MRA techniques. Gadolinium, the most common contrast agent used for MRI and MRA exams, has been directly linked to nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). NSF and NFD can be fatal in patients with renal insufficiency

For more information: www.medical.toshiba.com

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.